Literature DB >> 12473259

Electrocardiographic measures of left ventricular hypertrophy show greater heritability than echocardiographic left ventricular mass.

B M Mayosi1, B Keavney, A Kardos, C H Davies, P J Ratcliffe, M Farrall, H Watkins.   

Abstract

AIMS: To assess the heritability (i.e. relative contribution of genetic factors to the variability) of continuous measures of left ventricular hypertrophy determined by electrocardiography and echocardiography. METHODS AND
RESULTS: We studied 955 members of 229 Caucasian families, ascertained through a hypertensive proband. Electrocardiographic measurements were performed manually on resting 12-lead electrocardiograms, and echocardiographic measurements were made on M-mode images. Sex-specific residuals for the left ventricular phenotypes were calculated, adjusted for age, systolic blood pressure, weight, height, waist-hip ratio, and presence of diabetes. Heritability was estimated in two ways: firstly, from familial correlations with adjustment for spouse resemblance; and secondly by using variance components methods with ascertainment correction for proband status. The heritability estimates (given as a range derived from the two methods) were higher for Sokolow-Lyon voltage (39-41%) than for echocardiographic left ventricular mass (23-29%). Electrocardiographic left ventricular mass, Cornell voltage, and Cornell product had heritability estimates of 12-18%, 19-25%, and 28-32%, respectively.
CONCLUSIONS: Genetic factors may explain a substantial proportion of variability in quantitative electrocardiographic and echocardiographic measures of left ventricular hypertrophy. The greater heritability of Sokolow-Lyon voltage suggests that electrocardiographic phenotypes may be particularly important for the molecular investigation of the genetic susceptibility to cardiac hypertrophy. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12473259     DOI: 10.1053/euhj.2002.3288

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  27 in total

1.  Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure.

Authors:  B M Mayosi; A Kardos; C H Davies; F Gumedze; A Hovnanian; S Burge; H Watkins
Journal:  Heart       Date:  2005-04-21       Impact factor: 5.994

2.  Heritability of left ventricular mass and other morphologic variables in Caribbean Hispanic subjects: the Northern Manhattan Family Study.

Authors:  Suh-Hang Hank Juo; Marco R Di Tullio; Hsiu-Fen Lin; Tanja Rundek; Bernadette Boden-Albala; Shunichi Homma; Ralph L Sacco
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

Review 3.  Genetic inheritance effects on endurance and muscle strength: an update.

Authors:  Aldo M Costa; Luiza Breitenfeld; António J Silva; Ana Pereira; Mikel Izquierdo; Mário C Marques
Journal:  Sports Med       Date:  2012-06-01       Impact factor: 11.136

4.  Electrocardiographic indices of left ventricular hypertrophy and repolarization phase share the same genetic influences: a twin study.

Authors:  Sara Mutikainen; Alfredo Ortega-Alonso; Markku Alén; Jaakko Kaprio; Jouko Karjalainen; Taina Rantanen; Urho M Kujala
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-10       Impact factor: 1.468

5.  Heritability of left ventricular structure and function in Caucasian families.

Authors:  Yu Jin; Tatiana Kuznetsova; Murielle Bochud; Tom Richart; Lutgarde Thijs; Daniele Cusi; Robert Fagard; Jan A Staessen
Journal:  Eur J Echocardiogr       Date:  2011-03-11

6.  What can genetic studies of left ventricular mass tell us?

Authors:  Christopher Newton-Cheh
Journal:  Circ Cardiovasc Genet       Date:  2011-12

7.  Genetic influences on resting electrocardiographic variables in older women: a twin study.

Authors:  Sara Mutikainen; Alfredo Ortega-Alonso; Markku Alén; Jaakko Kaprio; Jouko Karjalainen; Taina Rantanen; Urho M Kujala
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

8.  Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy.

Authors:  Lize van der Merwe; Ruben Cloete; Miriam Revera; Marshall Heradien; Althea Goosen; Valerie A Corfield; Paul A Brink; Johanna C Moolman-Smook
Journal:  Hum Genet       Date:  2008-06-17       Impact factor: 4.132

9.  Genetic epidemiology of left ventricular hypertrophy.

Authors:  Jonathan N Bella; Harald Hh Göring
Journal:  Am J Cardiovasc Dis       Date:  2012-10-25

10.  Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy.

Authors:  Ingegerd Ostman-Smith; Aase Wisten; Eva Nylander; Ewa-Lena Bratt; Anne de-Wahl Granelli; Abderrahim Oulhaj; Erik Ljungström
Journal:  Eur Heart J       Date:  2009-11-05       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.